{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:06:19Z","timestamp":1790795179950,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,24]],"date-time":"2009-07-24T00:00:00Z","timestamp":1248393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00415-009-5256-6","type":"journal-article","created":{"date-parts":[[2009,7,23]],"date-time":"2009-07-23T20:37:49Z","timestamp":1248381469000},"page":"15-23","source":"Crossref","is-referenced-by-count":92,"title":["Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy"],"prefix":"10.1007","volume":"257","author":[{"given":"Karsten","family":"Schepelmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika E.","family":"Spottke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Grothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Heuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Vielhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Mylius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertold","family":"Schrank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,24]]},"reference":[{"key":"5256_CR1","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P","volume":"19","author":"JA Barber","year":"2000","unstructured":"Barber JA, Thompson SG (2000) Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 19:3219\u20133236","journal-title":"Stat Med"},{"key":"5256_CR2","doi-asserted-by":"crossref","unstructured":"Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases\/amyotrophic lateral sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \u201cClinical limits of amyotrophic lateral sclerosis\u201d workshop contributors. J Neurol Sci 124:96\u2013107","DOI":"10.1016\/0022-510X(94)90191-0"},{"key":"5256_CR3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","volume":"19","author":"J Carpenter","year":"2000","unstructured":"Carpenter J, Bithell J (2000) Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 19:1141\u20131164","journal-title":"Stat Med"},{"key":"5256_CR4","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.43.9.1779","volume":"43","author":"PB Christensen","year":"1993","unstructured":"Christensen PB, Jensen TS, Tsiropoulos I, Sorensen T, Kjaer M, Hojer-Pedersen E, Rasmussen MJ, Lehfeldt E, de Fine Olivarius B (1993) Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology 43:1779\u20131783","journal-title":"Neurology"},{"key":"5256_CR5","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani RJ (1993) An introduction to the bootstrap. Chapman and Hall, London"},{"key":"5256_CR6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199402243300806","volume":"330","author":"EJ Emanuel","year":"1994","unstructured":"Emanuel EJ, Emanuel LL (1994) The economics of dying. The illusion of cost savings at the end of life. N Engl J Med 330:540\u2013544","journal-title":"N Engl J Med"},{"key":"5256_CR7","unstructured":"Federal Statistical Office of Germany. http:\/\/www.destatis.de . (accessed 15 December 2008)"},{"key":"5256_CR8","unstructured":"Federal Statistical Office of Germany http:\/\/www.destatis.de (accessed 20 May 2009)"},{"issue":"3","key":"5256_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198","journal-title":"J Psychiatr Res"},{"key":"5256_CR10","unstructured":"German Diagnosis Related Groups (G-DRG) http:\/\/www.g-drg.de (accessed 15 December 2008)"},{"key":"5256_CR11","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in health and medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MC (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York"},{"key":"5256_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0022-510X(98)00192-0","volume":"160","author":"AM Gray","year":"1998","unstructured":"Gray AM (1998) ALS\/MND and the perspective of health economics. J Neurol Sci 160:2\u20135","journal-title":"J Neurol Sci"},{"key":"5256_CR13","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1111\/j.1528-1167.2006.00889.x","volume":"47","author":"HM Hamer","year":"2006","unstructured":"Hamer HM, Spottke A, Aletsee C, Knake S, Reis J, Strzelczyk A, Oertel WH, Rosenow F, Dodel R (2006) Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany. Epilepsia 47:2165\u20132172","journal-title":"Epilepsia"},{"key":"5256_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000110176","volume":"8","author":"AD Hillel","year":"1989","unstructured":"Hillel AD, Miller RM, Yorkston K, McDonald E, Norris FH, Konikow N (1989) Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 8:142\u2013150","journal-title":"Neuroepidemiology"},{"key":"5256_CR15","unstructured":"Institute for Quality and Efficiency in Health Care (IQWIG) Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System\u2014Version 2.0, http:\/\/www.iqwig.de\/methods.805.en.html . (accessed 20 May 2009)"},{"key":"5256_CR16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki","year":"2000","unstructured":"Jaretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"5256_CR17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.47.4_Suppl_2.126S","volume":"47","author":"LM Klein","year":"1996","unstructured":"Klein LM, Forshew DA (1996) The economic impact of ALS. Neurology 47:126\u2013129","journal-title":"Neurology"},{"key":"5256_CR18","unstructured":"Kobelt G, Berg J, Atherley D, Hadjimichael O, Joensson B (2004) Costs and quality of life in multiple sclerosis\u2014a Cross-Sectional Study in the USA. SSE\/EFI Working Paper Series in Economics and Finance No 594"},{"key":"5256_CR19","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/01.wnl.0000218309.01322.5c","volume":"66","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Berg J, Atherly D, Hadjimichael O (2006) Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Neurology 66:1696\u20131702","journal-title":"Neurology"},{"key":"5256_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10198-006-0384-8","volume":"7","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Berg J, Lindgren P, Berger K, Elias WG, Flachenecker P, Freidel M, Koenig N, Limmroth V, Straube E (2006) Costs and quality of life of multiple sclerosis in Germany. Eur J Health Econ 7:34\u201344","journal-title":"Eur J Health Econ"},{"key":"5256_CR21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1055\/s-2005-858698","volume":"67","author":"C Krauth","year":"2005","unstructured":"Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B (2005) Empirical standard costs for health economic evaluation in Germany\u2014a proposal by the working group methods in health economic evaluation. Gesundheitswesen 67:736\u2013746","journal-title":"Gesundheitswesen"},{"key":"5256_CR22","first-page":"281","volume":"36","author":"JF Kurtzke","year":"1982","unstructured":"Kurtzke JF (1982) Epidemiology of amyotrophic lateral sclerosis. Adv Neurol 36:281\u2013302","journal-title":"Adv Neurol"},{"key":"5256_CR23","first-page":"1","volume":"26","author":"J Lopez-Bastida","year":"2008","unstructured":"Lopez-Bastida J, Perestelo-Perez L, Monton-Alvarez F, Serrano-Aquilar P, Luis Alfonso-Sanchez J (2008) Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain. Amyotroph Later Scler 26:1\u20137","journal-title":"Amyotroph Later Scler"},{"key":"5256_CR24","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1212\/01.wnl.0000249311.80411.93","volume":"67","author":"J Lopez-Bastida","year":"2006","unstructured":"Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J (2006) Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. Neurology 67:2186\u20132191","journal-title":"Neurology"},{"key":"5256_CR25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/jmg.28.10.655","volume":"28","author":"PW Lunt","year":"1991","unstructured":"Lunt PW, Harper PS (1991) Genetic counselling in facioscapulohumeral muscular dystrophy. J Med Genet 28:655\u2013664","journal-title":"J Med Genet"},{"key":"5256_CR26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0272989X9901900401","volume":"19","author":"D Meltzer","year":"1999","unstructured":"Meltzer D, Johannesson M (1999) Inconsistencies in the \u201csocietal perspective\u201d on costs of the panel on cost-effectiveness in health and medicine. Med Decis Making 19:371\u2013377","journal-title":"Med Decis Making"},{"key":"5256_CR27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1378\/chest.110.1.249","volume":"110","author":"AH Moss","year":"1996","unstructured":"Moss AH, Oppenheimer EA, Casey P, Cazzolli PA, Roos RP, Stocking CB, Siegler M (1996) Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation. Advance care planning and outcomes. Chest 110:249\u2013255","journal-title":"Chest"},{"key":"5256_CR28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1108\/14777260410548437","volume":"18","author":"D Negrini","year":"2004","unstructured":"Negrini D, Kettle A, Sheppard L, Mills GH, Edbrooke DL (2004) The cost of a hospital ward in Europe: is there a methodology available to accurately measure the costs? J Health Org Manag 18:195\u2013206","journal-title":"J Health Org Manag"},{"key":"5256_CR29","unstructured":"OECD Purchasing Power Parities (PPPs) for OECD Countries 1980\u20132007: OECD. 2008. http:\/\/www.oecd.org\/dataoecd\/61\/56\/39653523.xls (accessed 15 Mai 2008)"},{"key":"5256_CR30","unstructured":"Official German doctor\u2019s fee scale (Einheitlicher Bewertungsmasstab) (2006) Deutscher Aerzteverlag, Koeln"},{"key":"5256_CR31","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/WNL.52.9.1822","volume":"52","author":"RW Orrell","year":"1999","unstructured":"Orrell RW, Tawil R, Forrester J, Kissel JT, Mendell JR, Figlewicz DA (1999) Definitive molecular diagnosis of facioscapulohumeral dystrophy. Neurology 52:1822\u20131826","journal-title":"Neurology"},{"key":"5256_CR32","volume-title":"Health-economic evaluations. (Gesundheits\u00f6konomische Evaluationen.)","author":"O Sch\u00f6ffski","year":"2007","unstructured":"Sch\u00f6ffski O, Graf von der Schulenburg J-M (2007) Health-economic evaluations. (Gesundheits\u00f6konomische Evaluationen.). Springer, Berlin"},{"key":"5256_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00019053-199711020-00005","volume":"11","author":"JE Siegel","year":"1997","unstructured":"Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR (1997) Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics 11:159\u2013168","journal-title":"Pharmacoeconomics"},{"key":"5256_CR34","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00019053-200523080-00007","volume":"23","author":"AE Spottke","year":"2005","unstructured":"Spottke AE, Reuter M, Machat O, Bornschein B, von Campenhausen S, Berger K, Koehne-Volland R, Rieke J, Simonow A, Brandstaedter D, Siebert U, Oertel WH, Ulm G, Dodel R (2005) Cost of illness and its predictors for Parkinson\u2019s disease in Germany. Pharmacoeconomics 23:817\u2013836","journal-title":"Pharmacoeconomics"},{"key":"5256_CR35","first-page":"574","volume":"38","author":"CA Swinyard","year":"1957","unstructured":"Swinyard CA, Deaver GC, Greenspan L (1957) Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch Phys Med Rehabil 38:574\u2013579","journal-title":"Arch Phys Med Rehabil"},{"key":"5256_CR36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","volume":"77","author":"R Tarricone","year":"2006","unstructured":"Tarricone R (2006) Cost-of-illness analysis. What room in health economics? Health Policy 77:51\u201363","journal-title":"Health Policy"},{"key":"5256_CR37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(01)00618-9","volume":"191","author":"M Tavakoli","year":"2001","unstructured":"Tavakoli M, Malek M (2001) The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK. J Neurol Sci 191:95\u2013102","journal-title":"J Neurol Sci"},{"key":"5256_CR38","unstructured":"The Federal Ministry for Health and Social Secure http:\/\/www.bmg.bund.de"},{"key":"5256_CR39","volume-title":"Rote Liste","author":"The Federation of German Pharmaceutical Industry","year":"2006","unstructured":"The Federation of German Pharmaceutical Industry (2006) Rote Liste. Rote Liste Verlag, Weinheim"},{"key":"5256_CR40","unstructured":"The German Federal Ministry of Justice http:\/\/www.bmj.bund.de (assessed 20 February 2009)"},{"issue":"1","key":"5256_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17482960802103131","volume":"10","author":"I Steen Van Der","year":"2009","unstructured":"Van Der Steen I, Van Den Berg JP, Buskens E, Lindeman E, Van Den Berg LH (2009) The costs of amyotrophic lateral sclerosis, according to type of care. Amyotroph Lateral Scler May 10(1):27\u201334","journal-title":"Amyotroph Lateral Scler May"},{"key":"5256_CR42","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s00115-008-2505-3","volume":"79","author":"Y Winter","year":"2008","unstructured":"Winter Y, Wolfram C, Sch\u00f6ffski O, Dodel RC, Back T (2008) Long-term disease-related costs 4\u00a0years after stroke or TIA in Germany. Nervenarzt 79:918\u2013926","journal-title":"Nervenarzt"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5256-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-5256-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5256-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:26:14Z","timestamp":1710505574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-5256-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,24]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["5256"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-5256-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,24]]}}}